MAPT and Alzheimer disease: AD is characterized clinically by a progressive cognitive impairment and pathologically by neurodegeneration and the presence of amyloid plaques composed of amyloid beta (Aβ) protein and neurofibrillary tangles composed of phosphorylated tau (Holtzman et al., 2011; Goate and Hardy, 2012).